子宮内膜症治療の世界市場2021年ー2027年:薬剤タイプ別(経口避妊薬、プロゲスチン、NSAID、GnRHアナログ、LNR-IUD、その他)、治療タイプ別、最終用途別、地域別

【英語タイトル】Global Endometriosis Treatment Market Size study, By Drug Type {Oral Contraceptives Progestins, NSAIDs, GnRH Analogues, LNR-IUDs, Others}, By Treatment Type {Hormonal Therapy, Pain Management}, By End-use{Hospital Pharmacies, Retail Pharmacies, Drug stores, e-Commerce}, Analysis Regional Forecasts 2021-2027

Bizwit Research & Consultingが出版した調査資料(BZW21AU095)・商品コード:BZW21AU095
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2021年8月
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:米国、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Research社は、2020年におよそXXX億ドルであった子宮内膜症治療の世界市場規模が、2021年から2027年の間に年平均XX%成長すると予測しています。本調査レポートは、世界の子宮内膜症治療市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、薬剤タイプ別(経口避妊薬、プロゲスチン、NSAID、GnRHアナログ、LNR-IUD)分析、治療タイプ別(ホルモン療法、疼痛管理)分析、最終用途別(病院薬局、小売薬局、ドラッグストア、eコマース)分析、地域別分析、競争状況、調査プロセスなど、以下の構成でまとめております。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・子宮内膜症治療の世界市場規模:薬剤タイプ別(経口避妊薬、プロゲスチン、NSAID、GnRHアナログ、LNR-IUD)
・子宮内膜症治療の世界市場規模:治療タイプ別(ホルモン療法、疼痛管理)
・子宮内膜症治療の世界市場規模:最終用途別(病院薬局、小売薬局、ドラッグストア、eコマース)
・子宮内膜症治療の世界市場規模:地域別
・競争状況
・調査プロセス

The global Endometriosis Treatment Market reached USD XXX Billion in 2020. The Global Endometriosis Treatment Market tends to grow by a CAGR of XX% in the 2021-2027 period.
When tissues that make up the lining of the uterus, grow outside of it, the disorder is called endometriosis. In Endometriosis, women face pain in the lower abdomen, cramps, and sometimes a high flow of blood. Endometriosis is divided into stages between level 1 (minimum or starting stage) to level 4 (severe or extreme stage). The established player has odds in their favor to lead the market and also expand their business portfolio by launching higher efficient and well-tested drugs into the market. One of the major trends that are driving this market is the awareness among women health and safety and governments investing into better treatment facilities and upgraded technologies used to reduce these diseases. Patient assistance programs are also spreading widely among various regions. However, limited availability of diagnostics is a major factor affecting this market negatively, but diagnostic facilities are expected to increase in the future. The ultrasound market is going to cover the largest market share, due to the upgradation in the technology and growing demand for diagnostic procedures. In 2018, Astellas Pharma announced the manufacturing of Opigolix drug that will be used for oral treatment of endometriosis.

The key regions covered in the global Endometriosis Treatment market are North America, Latin America, Europe, East Asia, South Asia-Pacific, and the Middle East & Africa. North America holds the largest market share, because of growing awareness about endometriosis treatment and the rate of incidences growing rapidly in that region. Due to higher population, growing market, and a large number of market players being present in the market, the Asia Pacific region is expected to grow in the future.

Major market players included in this report are:
Abbott Laboratories
AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Bayer AG
Eli Lilly and Company
Ipsen
Meditrina Pharmaceuticals Private Limited
Myovant Sciences Ltd
Neurocrine Biosciences Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:
Oral Contraceptives
Progestins
NSAIDs
GnRH Analogues
LNR-IUDs
Others

By Treatment Type:
Hormonal Therapy
Pain Management

By End-use:
Hospital Pharmacies
Retail Pharmacies
Drugstores
e-Commerce

By Region:
North America
The U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, the years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Endometriosis Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Oxytocic Pharmaceuticals Market, by Drug Type, 2019-2027 (USD Billion)
1.2.2. Oxytocic Pharmaceuticals Market, by Treatment Type, 2019-2027 (USD Billion)
1.2.3. Oxytocic Pharmaceuticals Market, by End-use, 2019-2027 (USD Billion)
1.2.4. Global Oxytocic Pharmaceuticals Market, by region, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Oxytocic Pharmaceuticals Market Definition and Scope
2.1. The objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Oxytocic Pharmaceuticals Market Dynamics
3.1. Global Oxytocic Pharmaceuticals Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing awareness about women health and safety
3.1.1.2. The surge in demand for patient assistance program
3.1.2. Market Challenges
3.1.2.1. Limited availability of diagnostics
3.1.3. Market Opportunities
3.1.3.1. Vertical business development (product expansions)
Chapter 4. Global Oxytocic Pharmaceuticals Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. The threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Oxytocic Pharmaceuticals Market by Drug Type
5.1. Market Snapshot
5.2. Global Oxytocic Pharmaceuticals Market by Drug Type, Performance – Potential Analysis
5.3. Global Oxytocic Pharmaceuticals Market estimates & Forecasts by Drug Type 2018-2027 (USD Billion)
5.4. Oxytocic Pharmaceuticals Market, Sub Segment Analysis
5.4.1. Oral Contraceptives
5.4.2. Progestins
5.4.3. NSAIDs
5.4.4. GnRH Analogues
5.4.5. LNR-IUDs
5.4.6. Others
Chapter 6. Global Oxytocic Pharmaceuticals Market by Treatment Type
6.1. Market Snapshot
6.2. Global Oxytocic Pharmaceuticals Market by Treatment Type, Performance – Potential Analysis
6.3. Global Oxytocic Pharmaceuticals Market estimates & Forecasts by Treatment Type 2018-2027 (USD Billion)
6.4. Oxytocic Pharmaceuticals Market, Sub Segment Analysis
6.4.1. Hormonal Therapy
6.4.2. Pain Management
Chapter 7. Global Oxytocic Pharmaceuticals Market by End-use
7.1. Market Snapshot
7.2. Global Oxytocic Pharmaceuticals Market by End-use, Performance – Potential Analysis
7.3. Global Oxytocic Pharmaceuticals Market estimates & Forecasts by End-use 2018-2027 (USD Billion)
7.4. Oxytocic Pharmaceuticals Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Drugstores
7.4.4. e-Commerce
Chapter 8. Global Oxytocic Pharmaceuticals Market, Regional Analysis
8.1. Global Oxytocic Pharmaceuticals Market, Regional Market Snapshot
8.2. North America Oxytocic Pharmaceuticals Market
8.2.1. U.S. Oxytocic Pharmaceuticals Market
8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Treatment Type breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-use breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Oxytocic Pharmaceuticals Market
8.3. Europe Oxytocic Pharmaceuticals Market Snapshot
8.3.1. The U.K. Oxytocic Pharmaceuticals Market
8.3.2. Germany Oxytocic Pharmaceuticals Market
8.3.3. France Oxytocic Pharmaceuticals Market
8.3.4. Spain Oxytocic Pharmaceuticals Market
8.3.5. Italy Oxytocic Pharmaceuticals Market
8.3.6. Rest of Europe Oxytocic Pharmaceuticals Market
8.4. Asia-Pacific Oxytocic Pharmaceuticals Market Snapshot
8.4.1. China Oxytocic Pharmaceuticals Market
8.4.2. India Oxytocic Pharmaceuticals Market
8.4.3. Japan Oxytocic Pharmaceuticals Market
8.4.4. Australia Oxytocic Pharmaceuticals Market
8.4.5. South Korea Oxytocic Pharmaceuticals Market
8.4.6. Rest of Asia Pacific Oxytocic Pharmaceuticals Market
8.5. Latin America Oxytocic Pharmaceuticals Market Snapshot
8.5.1. Brazil Oxytocic Pharmaceuticals Market
8.5.2. Mexico Oxytocic Pharmaceuticals Market
8.6. Rest of The World Oxytocic Pharmaceuticals Market

Chapter 9. Competitive Intelligence
9.1.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. AbbVie Inc.
9.2.3. Astellas Pharma Inc.
9.2.4. AstraZeneca PLC
9.2.5. Bayer AG
9.2.6. Eli Lilly and Company
9.2.7. Ipsen
9.2.8. Meditrina Pharmaceuticals Private Limited
9.2.9. Myovant Sciences Ltd
9.2.10. Neurocrine Biosciences Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Oxytocic Pharmaceuticals Market, report scope
TABLE 2. Global Oxytocic Pharmaceuticals Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Oxytocic Pharmaceuticals Market estimates & forecasts by Drug Type 2018-2027 (USD Billion)
TABLE 4. Global Oxytocic Pharmaceuticals Market estimates & forecasts by Treatment Type 2018-2027 (USD Billion)
TABLE 5. Global Oxytocic Pharmaceuticals Market estimates & forecasts by End-use 2018-2027 (USD Billion)
TABLE 6. Global Oxytocic Pharmaceuticals Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Oxytocic Pharmaceuticals Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Oxytocic Pharmaceuticals Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Oxytocic Pharmaceuticals Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Oxytocic Pharmaceuticals Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Oxytocic Pharmaceuticals Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Oxytocic Pharmaceuticals Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Oxytocic Pharmaceuticals Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Oxytocic Pharmaceuticals Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Oxytocic Pharmaceuticals Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row Oxytocic Pharmaceuticals Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row Oxytocic Pharmaceuticals Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of Oxytocic Pharmaceuticals Market
TABLE 56. List of primary sources, used in the study of Oxytocic Pharmaceuticals Market
TABLE 57. Years Considered for the study
TABLE 58. Exchange rates considered

List of figures
FIG 1. Global Oxytocic Pharmaceuticals Market, research methodology
FIG 2. Global Oxytocic Pharmaceuticals Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Oxytocic Pharmaceuticals Market, key trends 2020
FIG 5. Global Oxytocic Pharmaceuticals Market, growth prospects 2021-2027
FIG 6. Global Oxytocic Pharmaceuticals Market, porters 5 force model
FIG 7. Global Oxytocic Pharmaceuticals Market, pest analysis
FIG 8. Global Oxytocic Pharmaceuticals Market, value chain analysis
FIG 9. Global Oxytocic Pharmaceuticals Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Oxytocic Pharmaceuticals Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Oxytocic Pharmaceuticals Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Oxytocic Pharmaceuticals Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Oxytocic Pharmaceuticals Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Oxytocic Pharmaceuticals Market, regional snapshot 2018 & 2027
FIG 15. North America Oxytocic Pharmaceuticals Market2018 & 2027 (USD Billion)
FIG 16. Europe Oxytocic Pharmaceuticals Market2018 & 2027 (USD Billion)
FIG 17. Asia Pacific Oxytocic Pharmaceuticals Market2018 & 2027 (USD Billion)
FIG 18. Latin America Oxytocic Pharmaceuticals Market2018 & 2027 (USD Billion)
FIG 19. Global Oxytocic Pharmaceuticals Market, company market share analysis (2020)

★調査レポート[子宮内膜症治療の世界市場2021年ー2027年:薬剤タイプ別(経口避妊薬、プロゲスチン、NSAID、GnRHアナログ、LNR-IUD、その他)、治療タイプ別、最終用途別、地域別] (コード:BZW21AU095)販売に関する免責事項を必ずご確認ください。
★調査レポート[子宮内膜症治療の世界市場2021年ー2027年:薬剤タイプ別(経口避妊薬、プロゲスチン、NSAID、GnRHアナログ、LNR-IUD、その他)、治療タイプ別、最終用途別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆